Related Experiment Video
Updated: May 30, 2025

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
Alternative splicing of vascular calcification: Insights, opportunities, and challenges
Yingkun Sheng1, Hewen Wei2, Shengmin Lu3
1Xingzhi College, Zhejiang Normal University, Jinhua 321100, China.
Insights
Vascular calcification (VC) is a reversible condition linked to heart issues. Alternative splicing (AS) offers potential as biomarkers for early VC diagnosis and monitoring.
Area of Science:
- Biomedical research
- Cardiovascular science
- Molecular biology
Background:
- Vascular calcification (VC) is a significant risk factor for cardiovascular events, including myocardial infarction and sudden cardiac death.
- VC contributes to cardiac and arterial thickening, leading to conditions like coronary heart disease and heart failure.
- Despite being reversible, current clinical practices lack effective treatments to fully reverse or cure VC.
Purpose of the Study:
- To explore the role of alternative splicing (AS) in vascular calcification (VC).
- To highlight the potential of AS isoforms as biomarkers for early diagnosis and disease monitoring of VC.
- To provide insights into novel diagnostic and therapeutic strategies for VC.
Main Methods:
- Review of current literature on vascular calcification.
- Analysis of the role of alternative splicing in cardiovascular diseases.
- Identification of potential biomarker isoforms related to VC.
Main Results:
- Alternative splicing (AS) presents extensive potential for clinical applications, including disease diagnosis and therapeutic targeting.
- Different isoforms resulting from AS may serve as crucial indicators for VC.
- Understanding AS isoforms can aid in developing new diagnostic and therapeutic approaches for VC.
Conclusions:
- Early diagnostic markers for vascular calcification (VC) are crucial for improving patient outcomes.
- Alternative splicing (AS) isoforms show promise as valuable biomarkers for the early detection and monitoring of VC.
- Further research into AS in VC could lead to significant advancements in clinical management and treatment strategies.
Abstract:
Vascular calcification(VC) significantly increases the risk of cardiovascular events, leading to thickening of the myocardium and arteries, coronary heart disease, heart failure, and potentially triggering myocardial infarction and sudden cardiac death. Although VC is a reversible process, there are currently no methods or medications in clinical practice that can completely reverse or cure it. The current treatment strategies primarily focus on slowing the progression of VC and exploring new diagnostic and therapeutic approaches, making the identification of early diagnostic markers for VC particularly important. Alternative splicing(AS)has extensive potential in clinical applications as a biomarker, including in disease diagnosis and therapeutic targeting. This article provides an overview of the roles played by different isoforms of biomarkers in VC, with the aim of offering insights for early diagnosis and disease monitoring of VC.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing

